Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)

Genes Dev. 1999 Nov 15;13(22):3027-33. doi: 10.1101/gad.13.22.3027.

Abstract

The p16(INK4a) tumor suppressor inhibits cyclin-dependent kinases (CDK4 and CDK6). Here we report the isolation of a novel gene, SEI-1, whose product (p34(SEI-1)) appears to antagonize the function of p16(INK4a). Addition of p34(SEI-1) to cyclin D1-CDK4 renders the complex resistant to inhibition by p16(INK4a). Expression of SEI-1 is rapidly induced on addition of serum to quiescent fibroblasts, and ectopic expression of p34(SEI-1) enables fibroblasts to proliferate even in low serum concentrations. p34(SEI-1) seems to act as a growth factor sensor and may facilitate the formation and activation of cyclin D-CDK complexes in the face of inhibitory levels of INK4 proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Physiological Phenomena
  • COS Cells
  • Carrier Proteins / physiology*
  • Cell Cycle / physiology
  • Cells, Cultured
  • Chlorocebus aethiops
  • Chromosomes, Human, Pair 19 / genetics
  • Culture Media, Serum-Free
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase Inhibitor p16 / antagonists & inhibitors
  • Cyclin-Dependent Kinases / metabolism*
  • DNA, Complementary / genetics
  • Enzyme Activation
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology
  • Genes
  • HeLa Cells
  • Humans
  • Nuclear Proteins*
  • Proto-Oncogene Proteins*
  • Saccharomyces cerevisiae
  • Trans-Activators*
  • Transcription Factors
  • Transfection
  • Two-Hybrid System Techniques

Substances

  • Carrier Proteins
  • Culture Media, Serum-Free
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Complementary
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • SERTAD1 protein, human
  • Trans-Activators
  • Transcription Factors
  • CDK4 protein, human
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases

Associated data

  • GENBANK/AF117959